| |
Normo-albuminuric type 2 diabetes |
Micro-albuminuric type 2 diabetes |
| |
ACE genotypes |
T-test |
ACE genotypes |
T-test |
| |
II (n=18) |
ID/DD (n=32) |
t |
P-value |
II
(n=14) |
ID/DD
(n=36) |
t |
P-value |
| sRAGE, pg/mL |
2985 ± 310 |
3280 ± 155 |
3.19 |
0.004 |
4566 ± 219 |
4975 ± 256 |
3.71 |
0.001 |
| Pentosidineng/ml |
231 ± 66 |
289 ± 65 |
2.13 |
0.044 |
277 ± 15 |
305 ± 24 |
2.85 |
0.008 |
| AOPPs (μmol/l) |
169 ± 7.5 |
192 ± 4.9 |
9.30 |
<0.001* |
199 ± 7.6 |
207 ± 5.4 |
2.96 |
0.006 |
| Data presented as means± SD. P was calculated by T-test. P was considered significant at <0.05.;*SignificantsRAGE: soluble receptor for advanced glycation end-products, AOPP:advanced oxidation protein products |
|
